Biosensors Industry Analysis & Research: Worldwide Market Rising USD 31,920.4 Million by 2024

The published report title "Global Biosensors Market" is segmented on the basis of product type, application and end user. The report provides data for 2015 to 2024, 2016 being the current year while 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Global Biosensors Market is expected to reach 31,920.4 million by 2024 from 16,153.1 million in 2016, at a CAGR of 8.9% in the forecast period 2017 to 2024.

Get Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-biosensors-market

Segmentation of Global Biosensors Market:

Global Biosensors Market By Technology (Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Nanomechanical Biosensors, Thermal Biosensors, Others), By Product (Wearable Biosensors, Non-Wearable Biosensors), By Application (Point Of Care (POC), Home Diagnostics And Biodefence, Environmental Monitoring, Food & Beverage Industry, Research Labs), By Geography (North America, Europe, Asia-Pacific, South America, Middle East And Africa) – Industry Trends and Forecast to 2024

The global biosensors market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The Abbott is going to dominate the global biosensor market followed by Johnsons & Johnson Services, Inc., Medtronic and other players operating in this market are include DuPont, Bio-Rad Laboratories, Inc., Universal Biosensors Inc., Sysmex Corporation, Pharmaco-Kinesis, Nova Biomedical, ACON Laboratories, Inc., General Electric, DANAHER (Molecular devices, LLC), Drägerwerk AG & Co. KGaA, Ercon Inc., HMicro Inc. and Xsensio among others.

For Any Query Speak to Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-biosensors-market

Abbott:

Abbott was incorporated in 1900 and headquartered in Illinois, U.S. It is a globally diversified healthcare company focused in discovery, development, manufacture, and marketing of broad line of health care products. It operates its business through four segments, established pharmaceutical products, diagnostic products, nutritional products, and vascular products.

Abbott operates in more than 150 countries across United States, Europe, Western Hemisphere, Africa, and Asia-Pacific. For instance, Abbott Administration Inc. (Delaware), Abbott Home Infusion Services, Inc. (New york), Abbott Laboratories International Co. (Illinois), Abbott Australasia Pty Ltd.(Australia), Murex Diagnostics International, Inc. (Barbados), Abbott S.A. (Belgium).

Johnson & Johnson Services, Inc.:

Johnson & Johnson Services, Inc. founded in 1886 and headquartered at New Jersey, U.S. The company operates through three business segments, namely, Consumer, Pharmaceutical, and Medical Devices. The pharmaceutical segment offers a wide range of products for five major therapeutic applications—immunology, infectious diseases, neuroscience, oncology, and cardiovascular & metabolic diseases. The consumer segment of the company offers various products pertaining to baby care, oral care, skin care, women’s health, and wound care. The medical devices segment of the company offers various devices to be used in therapeutic areas such as orthopedic, surgical care, specialty surgery, cardiovascular care, diagnostics, diabetes care, and vision care.

Ethicon US, LLC., subsidiary of Johnson & Johnson Services, Inc. is engaged in the development and marketing of healthcare products.

Johnson & Johnson has more than 265 operating companies across the United States, Europe, Western Hemisphere, Africa, and Asia-Pacific. Some of its subsidiaries include Janssen Pharmaceuticals (Belgium), Ethicon Inc. (U.S.), DePuy (U.S.), Neutrogena (U.S.), Synthes (Switzerland), Cordis Corporation (U.S.), LifeScan, Inc. (U.S.), Janssen-Cilag (U.S.), McNeil Consumer Healthcare (U.S.), Janssen Biotech, Inc. (U.S.), Ortho Clinical Diagnostics (U.S.), and Mentor Worldwide LLC (U.S.).

Medtronic:

Medtronic was founded in 1949 and headquartered in Minneapolis, U.S. It is a global healthcare solutions company and it is the world’s largest standalone medical technology development company. The company operates in cardiac and vascular group, minimally invasive therapies group, restorative therapies group, and diabetes group. It offers absorbable and non-absorbable sutures through its subsidiaries brand name Covidien products.

The company operates in more than 155 countries worldwide with more than 260 locations in research and development, manufacturing and distribution, and education centers. The company’s regional locations are Asia-Pacific, Eastern Europe, Latin America, Middle East and Africa, Central Asia, South Asia, North America, and Western Europe.

Major Players of Global Biosensors Market:

The Abbott is going to dominate the global biosensor market followed by Johnsons & Johnson Services, Inc., Medtronic and other players operating in this market are include DuPont, Bio-Rad Laboratories, Inc., Universal Biosensors Inc., Sysmex Corporation, Pharmaco-Kinesis, Nova Biomedical, ACON Laboratories, Inc., General Electric, DANAHER (Molecular devices, LLC), Drägerwerk AG & Co. KGaA, Ercon Inc., HMicro Inc. and Xsensio among others.

Read more news about this Report visit @ http://databridgemarketresearch.com/reports/global-biosensors-market/

Table of Contents:

1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF GLOBAL BIOSENSOR MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. SIGNIFICANT TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF BIOSENSOR
3.1.2. EMERGENCE OF NANOTECHNOLOGY-BASED BIOSENSORS
3.1.3. INCREASING USE OF BIOSENSORS TO MONITOR GLUCOSE LEVELS IN INDIVIDUALS WITH DIABETES
3.1.4. HIGH DEMAND OF BIOSENSOR IN MONITORING AND DIAGNOSTIC DEVICES
3.1.5. RISING DEMAND FOR DISPOSABLE, COST-EFFICIENT, AND USER-FRIENDLY DEVICES

3.2. RESTRAINTS

3.2.1. SLOW RATE OF COMMERCIALIZATION
3.2.2. HIGH COSTS FOR INITIAL DEVELOPMENT

3.3. OPPORTUNITIES

3.3.1. GROWTH OPPORTUNITY IN ENVIRONMENTAL MONITORING, BIODEFENSE AND FOOD SECTOR
3.3.2. RISING DEMAND IN DEVELOPING COUNTRIES

3.4. CHALLENGES

3.4.1. STRINGENT GOVERNMENT REGULATIONS

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL BIOSENSOR MARKET, BY PRODUCT

6.1. OVERVIEW

6.2. WEARABLE BIOSENSORS

6.2.1. WRISTWEAR
6.2.2. EYEWEAR
6.2.3. FOOTWEAR
6.2.4. BODYWEAR
6.2.5. NECKWEAR
6.2.6. OTHERS

6.3. NON-WEARABLE BIOSENSORS

7. GLOBAL BIOSENSOR MARKET, BY APPLICATION

7.1. OVERVIEW

7.2. POINT OF CARE (POC)

7.2.1. GLUCOSE MONITORING
7.2.2. INFECTIOUS DISEASES
7.2.3. CARDIAC MARKERS
7.2.4. PREGNANCY & FERTILITY TESTING
7.2.5. TUMOR OR CANCER MARKERS
7.2.6. COAGULATION MONITORING
7.2.7. URINALYSIS TESTING
7.2.8. BLOOD GAS & ELECTROLYTES
7.2.9. CHOLESTEROL TESTS
7.2.10. OTHERS

7.3. HOME DIAGNOSTICS

7.4. ENVIRONMENTAL MONITORING

7.4.1. WASTEWATER TREATMENT

7.5. RESEARCH LABS

7.5.1. DRUG DEVELOPMENT

7.6. FOOD & BEVERAGES INDUSTRY

7.7. BIODEFENCE

7.7.1. CRIME DETECTION

7.8. OTHERS

8. GLOBAL BIOSENSOR MARKET, BY TECHNOLOGY

8.1. OVERVIEW

8.2. ELECTROCHEMICAL BIOSENSORS

8.2.1. AMPEROMETRIC SENSORS
8.2.1.1. BLOOD GLUCOSE SENSORS
8.2.2. POTENTIOMETRIC SENSORS
8.2.2.1. PENICILLIN BIOSENSOR
8.2.2.2. IMMUNOSENSORS
8.2.2.3. UREA BIOSENSOR
8.2.3. CONDUCTOMETRIC SENSORS

8.3. OPTICAL BIOSENSORS

8.3.1. FLUORESCENCE BIOSENSORS
8.3.2. SURFACE PLASMON RESONANCE (SPR)
8.3.3. CALORIMETRIC BIOSENSORS

8.4. PIEZOELECTRIC BIOSENSORS

8.4.1. ACOUSTIC BIOSENSORS
8.4.2. MICROCANTILEVER BIOSENSORS

8.5. NANOMECHANICAL BIOSENSORS

8.6. THERMAL BIOSENSORS

8.7. OTHERS

9. GLOBAL BIOSENSOR MARKET, BY GEOGRAPHY

9.1. OVERVIEW

9.2. NORTH AMERICA

9.2.1. U.S.
9.2.2. CANADA
9.2.3. MEXICO

9.3. EUROPE

9.3.1. GERMANY
9.3.2. FRANCE
9.3.3. U.K.
9.3.4. ITALY
9.3.5. SPAIN
9.3.6. SWITZERLAND
9.3.7. NETHERLANDS
9.3.8. TURKEY
9.3.9. BELGIUM
9.3.10. RUSSIA
9.3.11. REST OF EUROPE

9.4. ASIA-PACIFIC

9.4.1. JAPAN
9.4.2. CHINA
9.4.3. INDIA
9.4.4. SOUTH KOREA
9.4.5. AUSTRALIA
9.4.6. SINGAPORE
9.4.7. THAILAND
9.4.8. MALAYSIA
9.4.9. INDONESIA
9.4.10. PHILIPPINES
9.4.11. REST OF ASIA-PACIFIC

9.5. SOUTH AMERICA

9.5.1. BRAZIL
9.5.2. REST OF SOUTH AMERICA

9.6. MIDDLE EAST AND AFRICA

9.6.1. SOUTH AFRICA
9.6.2. REST OF MIDDLE EAST AND AFRICA

10. GLOBAL BIOSENSORS MARKET, COMPANY LANDSCAPE

10.1. COMPANY SHARE ANALYSIS: GLOBAL
10.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3. COMPANY SHARE ANALYSIS: EUROPE
10.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC

11. COMPANY PROFILES

11.1. ABBOTT

11.1.1. COMPANY OVERVIEW
11.1.2. ABBOTT: REVENUE ANALYSIS
11.1.3. PRODUCT PORTFOLIO
11.1.4. RECENT DEVELOPMENTS

11.2. MEDTRONIC

11.2.1. COMPANY OVERVIEW
11.2.2. MEDTRONIC: REVENUE ANALYSIS
11.2.3. PRODUCT PORTFOLIO
11.2.4. RECENT DEVELOPMENTS
11.3. JOHNSON & JOHNSON SERVICES, INC. (LIFESCAN, INC.)
11.3.1. COMPANY OVERVIEW
11.3.2. JOHNSON & JOHNSON SERVICES, INC: REVENUE ANALYSIS
11.3.3. PRODUCT PORTFOLIO
11.3.4. RECENT DEVELOPMENTS

11.4. UNIVERSAL BIOSENSORS INC.

11.4.1. COMPANY OVERVIEW
11.4.2. UNIVERSAL BIOSENSORS INC.: REVENUE ANALYSIS
11.4.3. PRODUCT PORTFOLIO
11.4.4. RECENT DEVELOPMENTS

11.5. DU PONT

11.5.1. COMPANY OVERVIEW
11.5.2. DUPONT: REVENUE ANALYSIS
11.5.3. PRODUCT PORTFOLIO
11.5.4. RECENT DEVELOPMENTS

11.6. SYSMEX CORPORATION

11.6.1. COMPANY OVERVIEW
11.6.2. SYSMEX CORPORATION: COMPANY SNAPSHOT
11.6.3. PRODUCT PORTFOLIO
11.6.4. RECENT DEVELOPMENTS

11.7. BIO-RAD LABORATORIES, INC.

11.7.1. COMPANY OVERVIEW
11.7.2. BIO-RAD LABORATORIES, INC.: REVENUE ANALYSIS
11.7.3. PRODUCT PORTFOLIO
11.7.4. RECENT DEVELOPMENTS

11.8. PHARMACO-KINESIS

11.8.1. COMPANY OVERVIEW
11.8.2. PHARMACO-KINESIS : COMPANY SNAPSHOT
11.8.3. PRODUCT PORTFOLIO
11.8.4. RECENT DEVELOPMENTS

11.9. NOVA BIOMEDICAL

11.9.1. COMPANY OVERVIEW
11.9.2. NOVA BIOMEDICAL: COMPANY SNAPSHOT
11.9.3. PRODUCT PORTFOLIO
11.9.4. RECENT DEVELOPMENTS

11.10. ACON LABORATORIES, INC.

11.10.1. COMPANY OVERVIEW
11.10.2. ACON LABORATORIES, INC.: COMPANY SNAPSHOT
11.10.3. PRODUCT PORTFOLIO
11.10.4. RECENT DEVELOPMENTS

11.11. GENERAL ELECTRIC

11.11.1. COMPANY OVERVIEW
11.11.2. GENERAL ELECTRIC: REVENUE ANALYSIS
11.11.3. PRODUCT PORTFOLIO
11.11.4. RECENT DEVELOPMENTS

11.12. XSENSIO

11.12.1. COMPANY OVERVIEW
11.12.2. XSENSIO: COMPANY SNAPSHOT
11.12.3. PRODUCT PORTFOLIO
11.12.1. RECENT DEVELOPMENTS

11.13. HMICRO INC.

11.13.1. COMPANY OVERVIEW
11.13.2. HMICRO INC.: COMPANY SNAPSHOT
11.13.3. PRODUCT PORTFOLIO
11.13.4. RECENT DEVELOPMENTS

11.14. ERCON INC.

11.14.1. COMPANY OVERVIEW
11.14.2. ERCON INC.: COMPANY SNAPSHOT
11.14.3. PRODUCT PORTFOLIO
11.14.4. RECENT DEVELOPMENTS

11.15. DRÄGERWERK AG & CO. KGAA

11.15.1. COMPANY OVERVIEW
11.15.2. DRÄGERWERK AG & CO. KGAA: REVENUE ANALYSIS
11.15.3. PRODUCT PORTFOLIO
11.15.4. RECENT DEVELOPMENTS

11.16. DANAHER(MOLECULAR DEVICES, LLC)

11.16.1. COMPANY OVERVIEW
11.16.2. DANAHER(MOLECULAR DEVICES, LLC): REVENUE ANALYSIS
11.16.3. PRODUCT PORTFOLIO
11.16.4. RECENT DEVELOPMENTS

12. RELATED REPORTS

Related Report

Global Milking Robots Market– Industry Trends and Forecast to 2024

Global Milking Robots market, By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa), By Offering (Hardware, Software, Service), System Type (Single-Stall Unit, Multi-Stall Unit, Automated Milking Rotary), Herd Size (Below 100, Between 100 and 1,000 and Above 1,000) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-milking-robots-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.